A Study of MLN8054 in Patients With Advanced Solid Tumors

Clinical trial NCT00249301 · TERMINATED

Trial details

NCT number: NCT00249301
Sponsor: Millennium Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasm Colon Neoplasm Pancreatic Neoplasm Bladder Neoplasm

Start date: 2005-10-01
Primary completion: 2008-01-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.